These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32464235)

  • 41. Targeting strategies for drug delivery to the kidney: From renal glomeruli to tubules.
    Liu CP; Hu Y; Lin JC; Fu HL; Lim LY; Yuan ZX
    Med Res Rev; 2019 Mar; 39(2):561-578. PubMed ID: 30136283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation of core cross-linked PCL-PEG-PCL micelles for doxorubicin delivery in vitro.
    Zhang J; Men K; Gu Y; Wang X; Gou M; Guo G; Luo F; Qian Z
    J Nanosci Nanotechnol; 2011 Jun; 11(6):5054-61. PubMed ID: 21770143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
    Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
    Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nano-encapsulation of a novel anti-Ran-GTPase peptide for blockade of regulator of chromosome condensation 1 (RCC1) function in MDA-MB-231 breast cancer cells.
    Haggag YA; Matchett KB; Dakir el-H; Buchanan P; Osman MA; Elgizawy SA; El-Tanani M; Faheem AM; McCarron PA
    Int J Pharm; 2017 Apr; 521(1-2):40-53. PubMed ID: 28163220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.
    Chen X; Zhang Y; Zhao P; Chen Y; Zhou Y; Wang S; Yin L
    Drug Dev Ind Pharm; 2020 Jan; 46(1):57-69. PubMed ID: 31813288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
    Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
    Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis.
    Prakash J; de Borst MH; van Loenen-Weemaes AM; Lacombe M; Opdam F; van Goor H; Meijer DK; Moolenaar F; Poelstra K; Kok RJ
    Pharm Res; 2008 Oct; 25(10):2427-39. PubMed ID: 18183478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanoparticles with CD44 Targeting and ROS Triggering Properties as Effective in Vivo Antigen Delivery System.
    Liang X; Li X; Duan J; Chen Y; Wang X; Pang L; Kong D; Song B; Li C; Yang J
    Mol Pharm; 2018 Feb; 15(2):508-518. PubMed ID: 29323913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation.
    Fu YC; Fu TF; Wang HJ; Lin CW; Lee GH; Wu SC; Wang CK
    Acta Biomater; 2014 Nov; 10(11):4583-4596. PubMed ID: 25050775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
    Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
    Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In Vivo Imaging of Small Molecular Weight Peptides for Targeted Renal Drug Delivery: A Study in Normal and Polycystic Kidney Diseased Mice.
    Lenhard SC; McAlexander A; Virtue A; Fieles W; Skedzielewski T; Rambo M; Trinh H; Cheng SH; Hong H; Isidro-Llobet A; Nadin A; Geske R; Klein JL; Lee D; Jucker BM; Hu E
    J Pharmacol Exp Ther; 2019 Sep; 370(3):786-795. PubMed ID: 30936291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
    El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
    Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
    Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
    Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of mycophenolic acid-glucosamine conjugates on the base of kidney targeted drug delivery.
    Wang X; Lin Y; Zeng Y; Sun X; Gong T; Zhang Z
    Int J Pharm; 2013 Nov; 456(1):223-34. PubMed ID: 23973508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epithelial cell adhesion molecule aptamer conjugated PEG-PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro.
    Alibolandi M; Ramezani M; Sadeghi F; Abnous K; Hadizadeh F
    Int J Pharm; 2015 Feb; 479(1):241-51. PubMed ID: 25529433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles.
    Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW
    Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: A novel approach for induction of apoptosis in HepG2 cell line.
    Abd-Rabou AA; Ahmed HH
    Adv Med Sci; 2017 Sep; 62(2):357-367. PubMed ID: 28521254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor-targeting peptide functionalized PEG-PLA micelles for efficient drug delivery.
    Cai Y; Xu Z; Shuai Q; Zhu F; Xu J; Gao X; Sun X
    Biomater Sci; 2020 Apr; 8(8):2274-2282. PubMed ID: 32162618
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transferrin-decorated thymoquinone-loaded PEG-PLGA nanoparticles exhibit anticarcinogenic effect in non-small cell lung carcinoma via the modulation of miR-34a and miR-16.
    Upadhyay P; Sarker S; Ghosh A; Gupta P; Das S; Ahir M; Bhattacharya S; Chattopadhyay S; Ghosh S; Adhikary A
    Biomater Sci; 2019 Oct; 7(10):4325-4344. PubMed ID: 31411213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.